Dukesking, That is a comprehensive list of possible combinations mostly related to CVD. If there is any significant value to be realized by any of such "combos" it would have to done by a BP capable of selling it. Without that these are worthless. I have doubts about combo drugs being viable as even though they may be more practical (especially if combined into a one a day combo product,) pharmacies would rather offer generics.
My opinion is I would rather see resources used to interest BP in uses of Vascepa (or a future one a day version) for other indications such as Alzheimers & Cancer. (I really would like to see a BP such as MRK which has the Cancer drug Keytruda do a study to find out if Vascepa with "any other Cancer drug or therapy" would lead to better outcomes for Cancer patients especially a reduction in complications. Imagine if a BP such as MRK believed that using Vascepa with any Cancer therapy/drug improved outcomes for patients! Now that would be worth a massive amount to that BP.